Impulsivity and Stillness: NADA, Pharmaceuticals, and Psychotherapy in Substance Use and Other DSM 5 Disorders

Behavioral Sciences

Kenneth Carter²  Michelle Olshan-Perlmutter¹ 

[1]Department of Psychiatry, Carolinas Healthcare System, 501 Billingsley Road, Charlotte, NC, 28211, USA, E-Mail

关键词: NADA;    impulsivity;    acudetox;    mindfulness;    pharmacology;    adjunctive treatment;    psychotherapy;    substance use disorder;    DSM;   

DOI  :  10.3390/bs5040537

来源: mdpi

【 摘 要 】

Pharmaceuticals and psychotherapy are commonly used in the management of impulsivity. The National Acupuncture Detoxification Association (NADA) protocol is an adjunctive therapy that involves the bilateral insertion of 1 to 5 predetermined ear needle points. One of the main benefits reported by patients, providers, and programs utilizing NADA is the sense of stillness, centering, and well-being. The induction of this attitude is seen as contributing to improved clinical outcomes including engagement and retention. The attitude of stillness is also suggestive of a pathway to mitigating impulsivity. Impulsivity is associated with substance use disorders and other DSM 5 diagnoses. Impulsivity has characteristics that are manifested clinically in behaviors such as disinhibition, poor self-control, lack of deliberation, thrill seeking, risk-taking. NADA holds promise as a useful treatment adjunct in the comprehensive management of disorders for which impulsivity is a prominent component.

【 授权许可】

CC BY   
© 2015 by the authors; licensee MDPI, Basel, Switzerland.